@misc{indiciaed60aa8fe2724,
  title = {A phase III prospective, randomized study to evaluate concentration-controlled sirolimus (rapamune) with cyclosporine dose minimization or elimination at six months in de novo renal allograft recipients.},
  author = {Keshwar Baboolal},
  year = {2003},
  doi = {10.1097/01.tp.0000063703.32564.3b},
  url = {https://pubmed.ncbi.nlm.nih.gov/12717239/},
  note = {Source identifier: 12717239}
}